| Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal Disease (NCT07580079) | Marc Donath | 2026-07-01 |
| BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT05393466) | Xcovery Holdings, Inc. | 2026-07-01 |
| Abdominal aBscess Catheter Sclerotherapy (ABCS) (NCT06906029) | University of Alabama at Birmingham | 2026-07-01 |
| Synthetic THC And Blood Pressure (NCT07231965) | Mayo Clinic | 2026-07-01 |
| A Phase 2 Study of HW211026 (NCT07513454) | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 2026-07-01 |
| Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder (NCT04649892) | University of Sao Paulo | 2026-07-01 |
| SONATA LIFU for OCD (NCT07728994) | University of Pennsylvania | 2026-07-01 |
| Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer (NCT07367178) | MedSIR | 2026-07-01 |
| A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension. (NCT07708441) | Shandong Suncadia Medicine Co., Ltd. | 2026-07-01 |
| A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia (NCT06327373) | Duke University | 2026-07-01 |
| Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors (NCT07738679) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma (NCT07632235) | Shanghai 6th People's Hospital | 2026-07-01 |
| Investigating the Clinical Benefits and Underlying Mechanisms of Danhong Injection in Modulating Mitochondrial Homeostasis Against Sepsis-Associated Myocardial Dysfunction (NCT07375862) | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 2026-07-01 |
| BCAAs in Concussion 3.0 (NCT07670195) | Akiva Cohen | 2026-07-01 |
| Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma (NCT06365619) | University of Utah | 2026-07-01 |
| Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer (NCT07665684) | University Health Network, Toronto | 2026-07-01 |
| Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery (NCT07686250) | H. Lee Moffitt Cancer Center and Research Institute | 2026-07-01 |
| Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLC (NCT07567326) | Peking University Cancer Hospital & Institute | 2026-07-01 |
| DaxibotulinumtoxinA for Blepharospasm (NCT07489430) | University of Pennsylvania | 2026-07-01 |
| Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J) (NCT07447557) | Elpida Therapeutics SPC | 2026-07-01 |
| A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease (NCT07633314) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (NCT07220252) | TG Therapeutics, Inc. | 2026-07-01 |
| Topical Carboxytherapy Paste Following Microneedling (NCT07431541) | Vanderbilt University Medical Center | 2026-07-01 |
| Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer (NCT07646301) | Sun Yat-sen University | 2026-07-01 |
| A Trial to Compare Treatment With Surlorian (ARM210, S48168) to Placebo in Effects on Muscle Strength and Safety in Adults With Autosomal Dominant RYR1-related Myopathy (NCT07560020) | RyCarma Therapeutics, Inc. | 2026-07-01 |
| (TNX-1500) in Kidney Transplant Recipients (NCT07204080) | Ayman Al Jurdi, MD | 2026-07-01 |
| Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) (NCT07011589) | M. Peter Marinkovich | 2026-07-01 |
| Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease (NCT07656688) | Huons Co., Ltd. | 2026-07-01 |
| Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II (NCT07131722) | PRG Science & Technology Co., Ltd. | 2026-07-01 |
| MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial). (NCT07593261) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2026-07-01 |
| Dapagliflozin Add-on in Unresectable HCC With Metabolic Syndrome (NCT07729592) | Sun Yat-sen University | 2026-07-01 |
| A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors (NCT05453851) | OHSU Knight Cancer Institute | 2026-07-01 |
| A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer (NCT07457164) | Antev Ltd. | 2026-07-01 |
| C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease (NCT06935474) | AbelZeta Inc. | 2026-07-01 |
| Combination of CXD and Restrictive Ketogenic Diet Against MASLD (NCT07639866) | Shanghai Municipal Hospital of Traditional Chinese Medicine | 2026-07-01 |
| Trastuzumab Rezetecan(SHR-A1811) Combined With Ivonescimab (AK112) in Locally Advanced or Metastatic Non-small Cell Lung Cancer Harboring HER2 Gene Abnormalities (NCT07630077) | Sun Yat-sen University | 2026-07-01 |
| Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial) (NCT05554419) | National Cancer Institute (NCI) | 2026-07-01 |
| Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes (NCT07616336) | Zhongshan Hospital (Xiamen), Fudan University | 2026-07-01 |
| "Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial" (NCT07684326) | Beni-Suef University | 2026-07-01 |
| Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (NCT07411378) | Biophytis | 2026-07-01 |
| A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis (NCT07660848) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-07-01 |
| Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial (NCT07650240) | Mayo Clinic | 2026-07-01 |
| A Study to Evaluate MAR002 for Acromegaly (NCT07641179) | Marea Therapeutics | 2026-07-01 |
| Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use (NCT07527338) | University of Colorado, Boulder | 2026-07-01 |
| Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF (NCT07687212) | The First Affiliated Hospital of Air Force Medicial University | 2026-07-01 |
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome (NCT07257978) | Fenix Innovation Group | 2026-07-01 |
| Perioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and Evacuation (NCT07537894) | Stanford University | 2026-07-01 |
| A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer (NCT07654400) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-07-01 |
| Oritavancin for Treatment of Serious Cardiac Infections (NCT07550595) | Kirby Institute | 2026-07-01 |
| TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis (NCT07176546) | Robert Spiera, MD | 2026-07-01 |
| Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer. (NCT07655661) | Ming Liu | 2026-07-01 |
| Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT (NCT07675174) | Northwell Health | 2026-07-01 |
| Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation (NCT06348147) | UNC Lineberger Comprehensive Cancer Center | 2026-07-01 |
| Testing the SurVaxM Vaccine for Lung Cancer Prevention (NCT07169617) | National Cancer Institute (NCI) | 2026-07-01 |
| BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder (NCT07596212) | University of Illinois at Chicago | 2026-07-01 |
| Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC (NCT07711470) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-07-01 |
| A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy (NCT07628738) | Ruijin Hospital | 2026-07-01 |
| A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL (NCT06979076) | MingSight Pharmaceuticals, Inc | 2026-07-01 |
| Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity (NCT07572175) | Icahn School of Medicine at Mount Sinai | 2026-07-01 |
| Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone Lymphoma (NCT07654465) | Sun Yat-sen University | 2026-07-01 |
| A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa (NCT07727889) | Peking Union Medical College | 2026-07-01 |
| Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder (NCT06651541) | Biozeus Biopharmaceutical S.A. | 2026-07-01 |
| A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors (NCT07623707) | FutureGen Biopharmaceutical (Beijing) Co., Ltd | 2026-07-01 |
| Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients (NCT07597941) | The Affiliated People's Hospital of Ningbo University | 2026-07-01 |
| The Impact of Palatal Rugae Addition to Complete Dentures on Patients' Satisfaction and Oral Health Related Quality of Life (NCT07034079) | Pakistan Institute of Medical Sciences | 2026-07-01 |
| A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer (NCT07678957) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-07-01 |
| Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response (NCT07670715) | Tianjin Medical University Cancer Institute and Hospital | 2026-07-01 |
| Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer (NCT07717242) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-07-01 |
| SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension (NCT07266519) | Philipps University Marburg | 2026-07-01 |
| A Phase Ib/II Study of BM230 in Combination With PD-1 Inhibitor for HER2-related Advanced Solid Tumors (NCT07698587) | Suzhou Biomissile Pharmaceuticals Co., Ltd. | 2026-07-01 |
| Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma (NCT07527325) | University of California, Irvine | 2026-07-01 |
| Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria (NCT07512596) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure (NCT07619898) | Therakos LLC | 2026-07-01 |
| Uterine Transplant in Absolute Uterine Infertility (AUIF) (NCT02741102) | Brigham and Women's Hospital | 2026-07-01 |
| Multiregion BHA in Open Tibia Fractures (NCT04056429) | Carmell Therapeutics Corporation | 2026-07-01 |
| Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL (NCT07692399) | Huashan Hospital | 2026-07-01 |
| A PHASE IB/II STUDY TO EVALUATE SAFETY AND EFFICACY OF BEXMARILIMAB IN COMBINATION WITH DOXORUBICIN IN METASTATIC SOFT-TISSUE SARCOMA (NCT07460986) | MedSIR | 2026-07-01 |
| Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study (NCT07486869) | University of Miami | 2026-07-01 |
| Yeast Protein for Muscle Mass (NCT07561619) | University of Alberta | 2026-07-01 |
| Stimulation-based Therapy to Improve Balance in DCM (NCT07298460) | Medical College of Wisconsin | 2026-07-01 |
| Tirzepatide for the Treatment of Cannabis Use Disorder (NCT07265752) | Brigham and Women's Hospital | 2026-07-01 |
| Efficacy and Mechanism of IPSRT for Bipolar II Disorder (NCT07654348) | First Affiliated Hospital of Zhejiang University | 2026-07-01 |
| A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer (NCT07653685) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2026-07-01 |
| Psilocybin Efficacy With or Without Pimavanserin Pretreatment (NCT07610135) | Johns Hopkins University | 2026-07-01 |
| Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma (NCT07529808) | BigHat Biosciences, Inc. | 2026-07-01 |
| Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation (NCT07501078) | Muhammad N Aslam, MD | 2026-07-01 |
| Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants (NCT07666750) | International Vaccine Institute | 2026-07-01 |
| Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma (NCT07612098) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-07-01 |
| The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma (NCT07565285) | Primmune Therapeutics, Inc. | 2026-07-01 |
| Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH) (NCT07601295) | Stanford University | 2026-07-01 |
| A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS (NCT06906471) | Antelope Surgical Solutions, Inc | 2026-07-01 |
| Combination Immunotherapy Targeting Sarcomas (NCT04433221) | Shenzhen Geno-Immune Medical Institute | 2026-07-01 |
| Vorinostat for Graft-versus-host Disease (GVHD) Prevention in Non-Malignant Adolescent and Young Adults (AYA) Population (NCT06995521) | Sung Won Choi | 2026-07-01 |
| Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma (NCT07665190) | Tianjin Medical University Cancer Institute and Hospital | 2026-07-01 |
| Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) (NCT07097311) | Jerry Vockley, MD, PhD | 2026-07-01 |
| A Reduced Dose of Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss (NCT06909123) | Stanford University | 2026-07-01 |
| Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV (NCT07007221) | University of Minnesota | 2026-07-01 |
| A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis (NCT07020715) | University Hospital, Antwerp | 2026-07-01 |
| Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R) (NCT06291103) | University Hospital, Rouen | 2026-07-01 |
| Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH) (NCT07441200) | NS Pharma, Inc. | 2026-07-01 |